Last edition
News about "Krishna Kanumuri, CEO and Managing Director (MD), "
Sai Life Sciences Completes Phase-II of Production Block 11 at Bidar site
Sai Life Sciences’ Unit IV in Bidar is the company’s flagship manufacturing site, specialising in the production of APIs and advanced intermediates for markets such as the US, EU and Japan.
Krishna Kanumuri, CEO And Managing Director (MD), | 29/08/2025 | By Dineshwori | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members